4//SEC Filing
HENDERSON LORI M. 4
Accession 0001127602-21-016541
CIK 0001682852other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:05 PM ET
Size
12.1 KB
Accession
0001127602-21-016541
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
HENDERSON LORI M
General Counsel and Secretary
Transactions
- Exercise/Conversion
Common Stock
2021-05-11$14.85/sh+6,170$91,625→ 7,501 total - Sale
Common Stock
2021-05-11$151.31/sh−6,600$998,646→ 901 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-11−6,170→ 361,352 totalExercise: $14.85Exp: 2028-06-26→ Common Stock (6,170 underlying) - Exercise/Conversion
Common Stock
2021-05-11$20.93/sh+430$9,000→ 1,331 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-11−430→ 93,046 totalExercise: $20.93Exp: 2029-03-08→ Common Stock (430 underlying)
Footnotes (3)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
- [F2]25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- [F3]25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001221127
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:05 PM ET
- Size
- 12.1 KB